Time of Day Dependent Effectiveness of Anti-IgE Therapy in Asthma: Clinical and Experimental Evidence
This study demonstrates that the effectiveness of anti-IgE therapy (omalizumab) for asthma is time-dependent, with both clinical data and murine experiments showing significantly better therapeutic outcomes when the initial dose is administered in the afternoon compared to the morning.